Limited inclusion in clinical trials and access to poly (ADP-ribose) polymerase inhibitors in racial and ethnic minority patients with cancer: a narrative review.
- DOI
- 10.1093/oncolo/oyag291
- Published
- 2026 Aug 6
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyag291,
title = {Limited inclusion in clinical trials and access to poly (ADP-ribose) polymerase inhibitors in racial and ethnic minority patients with cancer: a narrative review.},
author = {Swearingen A and Audu B and Hamidu A and Mustapha A and Oguntayo A and Yahya A and Bello A and Butler R and Halliday D and Bowe S and Jordan S and Hew K and Pinto A and Castillo RP and Reis IM and George S and Schlumbrecht M},
year = {2026},
journal = {The oncologist},
doi = {10.1093/oncolo/oyag291},
url = {https://doi.org/10.1093/oncolo/oyag291}
}RIS
TY - JOUR TI - Limited inclusion in clinical trials and access to poly (ADP-ribose) polymerase inhibitors in racial and ethnic minority patients with cancer: a narrative review. AU - Swearingen A AU - Audu B AU - Hamidu A AU - Mustapha A AU - Oguntayo A AU - Yahya A AU - Bello A AU - Butler R AU - Halliday D AU - Bowe S AU - Jordan S AU - Hew K AU - Pinto A AU - Castillo RP AU - Reis IM AU - George S AU - Schlumbrecht M PY - 2026 JO - The oncologist DO - 10.1093/oncolo/oyag291 UR - https://doi.org/10.1093/oncolo/oyag291 ER -
APA
A, S., B, A., A, H., A, M., A, O., A, Y., A, B., R, B., D, H., S, B., S, J., K, H., A, P., RP, C., IM, R., S, G., & M, S. (2026). Limited inclusion in clinical trials and access to poly (ADP-ribose) polymerase inhibitors in racial and ethnic minority patients with cancer: a narrative review.. The oncologist. https://doi.org/10.1093/oncolo/oyag291
Source records
- pubmed · retrieved 2026-09-26T10:27:29.884Z